Jubilant Ingrevia informs about outcome of board meeting

30 Jan 2024 Evaluate
In terms of Regulation 33 read with Regulation 30 of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (the ‘Listing Regulations’) and SEBI Circular No. SEBI/HO/DDHS/DDHS_Div1/P/CIR/2022/0000000103 (as amended), Jubilant Ingrevia has informed that the Unaudited Financial Results (Standalone and Consolidated) of the Company for the quarter ended December 31, 2023 were approved by the Board of Directors of the Company at its meeting held today at 11:45 am and concluded at 2:45pm. Pursuant to applicable provisions of the Listing Regulations, the company has enclosed: The Unaudited Financial Results (Standalone and Consolidated) for the quarter ended December 31, 2023, Limited Review Reports on the Unaudited Financial Results (Standalone and Consolidated) for the said quarter, Declaration for unmodified Auditors’ Report (Standalone and Consolidated) and The Board has declared an Interim Dividend of Rs 2.50 per equity share of Re 1 each on the paid-up Equity Share capital of the Company for the Financial Year 2023-24. Further, in terms of Regulation 42 of the Listing Regulations, the Board has fixed Friday, February 9, 2024 as ‘Record Date’ for the purpose of ascertaining eligibility of the shareholders for payment of Interim Dividend. The Interim Dividend will be paid/ dispatched on or before February 28, 2024.

The above information is a part of company’s filings submitted to BSE.

Jubilant Ingrevia Share Price

513.55 -5.85 (-1.13%)
14-May-2024 14:05 View Price Chart
Peers
Company Name CMP
Tata Chemicals 1060.55
SRF 2270.20
Pidilite Inds. 2990.00
Aarti Inds 657.75
Gujarat Fluorochemic 3253.55
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.